|
|
|
|
Direct Cost |
Indirect Cost |
|
1F31CA232403-01 |
The NuRD Complex Regulates ZEB1 Dimerization and NSCLC Metastasis |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$31,539 |
|
$31,539 |
1F32EB024379-01A1 |
SUPR peptides for tumor glycosylated MUC1 imaging |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIBIB |
$59,038 |
|
$59,038 |
1K08CA234333-01 |
Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$231,957 |
$18,557 |
$250,514 |
1K99CA218891-01A1 |
Targeting malic enzyme 3 as a synthetic lethality target in pancreatic cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$79,075 |
$6,326 |
$85,401 |
1K99CA225633-01A1 |
Determining structural features of a collagen lysyl hydroxylase that promotes lung cancer metastasis |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$103,550 |
$8,284 |
$111,834 |
1K99CA225756-01A1 |
Paracrine Role of Endothelial Cells in HER3-Mediated Colon Cancer Cell Survival |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$78,303 |
$6,264 |
$84,567 |
1K99CA226360-01A1 |
Novel Therapeutic Approaches Targeting Tumor Suppressor Deficiencies in Advanced Prostate Cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$85,444 |
$6,836 |
$92,280 |
1K99DA044277-01A1 |
Social Influence Strategies during a Web-based Smoking Prevention Intervention for Adolescents |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIDA |
$91,242 |
$7,299 |
$98,541 |
1R01AI133822-01A1 |
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIAID |
$268,376 |
$161,026 |
$429,402 |
1R01CA204665-01A1 |
Genomics of HCC in the Hispanic population of Texas |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$297,609 |
$92,854 |
$390,463 |
1R01CA214723-01A1 |
The E2F1 Post-Translational Modification Code |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$279,240 |
$165,122 |
$444,362 |
1R01CA214749-01A1 |
MSC-Derived Exosomes and MicroRNA in Glioma Therapy |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$228,750 |
$137,250 |
$366,000 |
1R01CA214954-01A1 |
Activating p53 for colorectal cancer prevention |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$290,071 |
$149,633 |
$439,704 |
1R01CA217931-01A1 |
Pre-metastatic Omental Niche Formation in Ovarian Cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$244,747 |
$138,382 |
$383,129 |
1R01CA218004-01A1 |
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$373,499 |
$224,099 |
$597,598 |
1R01CA218139-01A1 |
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$248,161 |
$131,296 |
$379,457 |
1R01CA218230-01A1 |
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$414,999 |
$248,999 |
$663,998 |
1R01CA219896-01A1 |
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$296,340 |
$133,603 |
$429,943 |
1R01CA221971-01A1 |
Optimization and Evaluation of Anatomical Models of Liver Radiation Response |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$228,750 |
$133,682 |
$362,432 |
1R01CA222007-01A1 |
miR-155 targeted therapeutics for precision medicine in lung cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$364,392 |
$172,282 |
$536,674 |